Rm2 Share Discussion Threads

[pugugly] 12/4/2017 11:09

JakNife - Looks interesting - However apears very much a start-up and apart from initial PR via BASF cannot find much more on the web and ahmar's own limited website details - Nothing on adopters or costs - I suspect they may be having similar traction difficulties as RM2. Also as private company no published accounts.

Initial reaction could give RM2 serious competition.

[pugugly] 03/4/2017 15:57

Another Woodford problem child Could fall today be PI's selling for a tax loss or still fundamental problems - I suspect still the latter and the poison pill of the prefs.

[dr biotech] 31/3/2017 17:10

I don't think you can ever read too much into single trades.

We need some sort of update on production and sales. Knowing how many they are trying to make and where they're headed..

[pugugly] 31/3/2017 16:15

Continuing to drift down - but if sacred entrails read correctly 44,029 picked up at only 22.685p - Big question What does he/she know or just a gamble ?

Most of the rest of today's action appears to be sells after 12:00 at below 22.5p. Tax loss selling ?

Edited after close. Another 50k appear to have been bought at 23p - ?? Could an institution be starting to build a position if all guessed buys today are the same buyer ? As seems a bit heavy for a PI.

[pugugly] 15/3/2017 09:34

Agreed Dr B. but no use manufacturing for stock - The production needs to be leased or sold. Ah well time will tell. Still on the side haveing sold out at 66p and 46p.


In addition Dr B i have recently revisited the terms of th Preference Shares - A dividend of 9% when any dividends declareable - Assuming the extra $10 million worthh are issued and assuming the same exchange rate (but now worse) the sterling issue price for the prefs (assuming a total issue of 63,500,000 prefs) at 35p per share to give a round figure cost of say £22,222,000 will require a dividend payment of £2,000,000 p/a before any dividend payable to the ordinaries and the Prefs ALSO are entitled to the ordinary dividend on top. Will the company ever earn sufficient to pay the dividend/s and/or buy them back "The Company shall (having providing 60 days written notice to the holders of the Preferred Shares) redeem the Preferred Shares on the fifth anniversary of the date of their issuance by paying in cash an amount equal to the Price per Share plus any declared but yet unpaid dividends."

I was thinking of having a small punt at thsi price but having checked the conditions have decided to stay on the side. e&oe. I think I have done the calculations correctly - can someone double check me please

[dr biotech] 14/3/2017 20:25

Only recent RNS was that Walmart (guess) found them acceptable. Hard to know what is the total level of usage. Will most of their customers be using 1000, or 10000 or more? If they are having a lot of success at a lower level then it's great but not RNS worthy....

We should be due another manufacturing RNS soon, a general update would be midst welcome

[pugugly] 14/3/2017 11:57

300,000 dumped at 24.05p - Someone seems to be taking a big hit - An institution loosing faith ? If so could be the start of a futher melt down.

No indication yet from the coy ON THE DEPTH of take up - The message I receive from the latest rns's is that potential depth of acceptance is still mainly in a suck-and-see mode.

As a poster has previously noted Industry awards may give a nice warm feeling BUT are no substitute for profitable sales or leasing contacts. (All imo etc)

[dr biotech] 13/3/2017 18:48

Humptydumpty- RM2 aren't American, and have never manufactured in the US. Are you using alternative facts?

[hamidahamida] 13/3/2017 10:37

One big problem Trump doesn't like American companies manufacturing abroad and selling back to America and these guys have moved all their production abroad. BIG PROBLEM!!!!

[pugugly] 20/2/2017 18:24

remarkomsoc:> Well done noticing - YES HE DID !! Typifies for me the coys lack of attention to detail - If the CEO can be so sloppy it sends the wrong message to the employees - No six sigma !!

[dr biotech] 20/2/2017 18:14

V unusual for the non-execs to take shares where the strike price is more than 3x the current price...hoping that the troubles are largely behind them. Only makes a small part of my holding, obcviously not without risk.

Woodford record is unsurprisingly better than mine, though as you say he is not infallible and has picked some real dogs over the last couple of years. NWBO, sphere medical, RR, amongst others. Has done well with others of course. hope this will be one of them.

[pugugly] 20/2/2017 17:48

Dr B - Not really - They had to do something to reassure the market and Major Shareholder possibly insisted that they do this to motivate them to perform. Woodford must be spitting blood at their apparent failure to perform.

A previous holder who believed in Woodford but now realise he does not walk on water but still watching and waiting for a reasonable re-entry point.

[dr biotech] 20/2/2017 13:55

John Walsh, RM2 CEO, said, "We are happy with progress we have made with our production partners and we have recently announced agreements with major North American corporations. We look forward to updating the market in the near future on production and customers in the near future."

Not greatly worded...their RNS's are a bit sloppy. Hopefully some more positive news soon. Good that the directors have taken options at 100p rather than cash. Shows a decent degree of faith.

[dr biotech] 17/2/2017 08:17

What does it say?


Always seems to spike on news then drops down when things go quiet. Would always like an update on sales and production. Are we picking up the smaller customers who use a few thousand?

[nw99] 16/2/2017 21:38

Shs mag today bullish

[nw99] 13/2/2017 15:28

No negatives then

[dr biotech] 13/2/2017 15:13

EGM agenda can be found here. Nothing particularly interesting


hxxp://rm2.com/wp-content/uploads/2017/02/convocation-200217.pdf

[solrei] 06/2/2017 12:52

They were also pleased to announce their last placing!